Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03424343

Longitudinal Identity Study of Childhood Cancer Survivors

The study investigators plan to conduct a longitudinal questionnaire study in adolescents and emerging adults (14-25 years of age at the start of the study) who survived childhood cancer to chart their identity development and broader social functioning. Additionally, the functioning of these survivors will be related to the functioning of their parents and siblings. The investigators shall focus especially on the current experience and impact of the earlier cancer experience. They will investigate to what extent the experience of a life-threatening disease has an effect on the daily life of survivors and over time and how the survivors develop through the course of adolescence and emerging adulthood on the psychosocial level. The formation of an adult identity is a very challenging task during adolescence and the way to adulthood and the fact that these youth had cancer during their childhood may especially complicate this process of identity formation. Furthermore, both parental and sibling functioning will be taken into account, which will allow us to examine inter-generational mechanisms (thus parental functioning that possibly impacts youth functioning and vice versa) and sibling functioning in these families. To investigate the latter, at each timepoint of the longitudinal study a sibling between 14 and 25 years of age at the start of the study will be included (if there is more than one sibling in a family, ideally the sibling who is closest in age will be the one who participates in the study). Moreover, a community sample that is matched on age and sex with the survivor of pediatric cancer will be assessed. This will allow the investigators to make well-founded comparisons regarding identity development and broader psychosocial functioning.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Pediatric Cancer Neoplasms

Age range

14 year–25 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Gasthuisberg

Leuven, Vlaams-Brabant, 3000, Belgium

About this study

In the present longitudinal study, four main research questions will be investigated.

  • How does identity develop in cancer survivors? Based on previous findings from studies in identity development, it seems that young adults with a chronic disease like type 1 diabetes show less exploration or consider less identity possibilities from which they can choose, e.g. they dwell less upon the choice of education. Does this finding also apply to survivors of childhood cancer or are these youth more similar to a community sample? This research question may provide an answer to the question whether or not there is a continued (psychological) impact of childhood cancer on the later identity development of survivors. For this purpose the investigators shall make use of an identity model which was developed at their research department and which has gained much international research attention. In addition, the investigators want to look at illness-identity, which comprises the amount to which the earlier cancer experience is integrated into one's identity. Does the youngster feel still engulfed by the earlier cancer experience, or has he/she integrated this experience as part of his/her self-concept? Or does the youngster feel even enriched by the earlier cancer experience, thus did he/she end up even stronger through the experience?
  • How do survivors of pediatric cancer and/or their parents function on the psychological level, more specific on the level of life satisfaction and depressive symptoms, and what is the role of identity and personality variables herein? This question examines, among other factors, concepts like benefit-finding, post-traumatic growth, resilience,... Thereby it would be interesting to examine whether different subgroups can be identified, for example, which groups of persons display less adaptive functioning and why?
  • Are there certain parenting dimensions (e.g. overprotection, responsiveness, psychological control,...) which are more prevalent in families that were confronted with pediatric cancer and are these dimensions differently related to the psychosocial adaptation of survivors? Does this relate to certain aspects of survivor functioning, like depressive symptoms and quality of life? Thereby, transactional processes between survivor and parental functioning will be investigated, e.g. does identity development of survivors have an impact on parental well-being, and has parental well-being in turn an impact on survivor functioning? Taken together, the investigators want to investigate to what extent these contextual variables determine the functioning of adolescents and emerging adults.
  • What is the impact for siblings of cancer survivors? How do they go through their identity process? Do they experience the same parenting as the survivors experience themselves? E.g if survivors would experience more parental overprotection, would siblings experience overprotection to the same extent?

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Survivors of childhood leukemia/lymphoma, solid tumors, and brain tumors, of whom the treatment has ended.
  • 14-25 years at the start of the study
  • Treated at the department of pediatric oncology at University Hospital Leuven, Belgium.
  • Sufficient knowledge of Dutch

Exclusion criteria

  • Mental retardation which hinders completion of the questionnaire bundle
  • Younger than 14 year and older than 25 year
  • Physically incapable to complete the questionnaire bundle
  • Insufficient knowledge of Dutch
  • Contact information is not available

Treatment and study plan

Questionnaire bundle

Other

Questionnaires on identity formation and psychosocial functioning, assessed and reported at baseline, one year later, two years later, and five years later.

Obtaining information from survivors' medical file

Other

After obtaining informed consent, we will access the medical file of participants to obtain information on the diagnosis, time of diagnosis, treatment duration, type of treatment, and relapse (when applicable).

Primary outcomes

  1. Change in Dimensions of Identity Development

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Dimensions of Identity Development Scale (DIDS); dimensions: commitment making (range: 5 - 25), Identification with Commitment (range: 5 - 25), Exploration in Breadth (rang: 5 - 25), Exploration in Depth (range: 5 - 25), Ruminative Exploration (range: 5 - 25); for each dimension, a higher score indicates more identification with the dimension

  2. Change in Identity from an Eriksonian Perspective

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Erikson Psychosocial Stage Inventory (EPSI); subscales: Synthesis (range: 5 - 30), Confusion (range: 5 - 30); for each scale, higher scores indicate more identification with the scale

  3. Change in Illness Centrality

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Illness Centrality; total scale range: 0 - 4; A higher score indicates more identification with the scale

  4. Change in Self-Identity after Cancer

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Self-Identity after Cancer; dimensions: victim of cancer (range: 1 - 5), cancer patient (range: 1 - 5), person who had cancer (range: 1 - 5), survivor (range: 1 - 5); for each dimension, a higher score indicates more identification with the dimension

Secondary outcomes

  1. Change in Post-Traumatic Stress Symptoms (measured in survivors)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Children's Revised Impact of Event Scale (CRIES-13); total scale range: 0 - 65; Higher scores indicate more sensitivity for PTSD; A score higher than 30 possibly indicates the presence of PTSD; subscales: Intrusion (range: 0 - 20), Avoidance (range: 0 - 20), Arousal (range: 0 - 25); Higher scores indicate more identification with the scale

  2. Change in Illness-related Benefit Finding (measured in survivors)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Benefit scale from the Benefit and Burden Scale (BBSC); total scale range: 10 - 50; A higher score indicates more identification with the scale

  3. Change in Depressive Symptoms (measured in survivors, siblings, and parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Center for Epidemiologic Studies Depression (CES-D-12); total scale range: 0 - 36; a higher score indicates the presence of more depressive symptoms

  4. Change in Cancer-related Worries (measured in survivors and parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Cancer Related Worries Scale; total scale range: 4 - 20; A higher score indicates the presence of more cancer-related worries

  5. Change in Global Life Satisfaction (measured in survivors, siblings and parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Satisfaction with Life Scale (SWLS); total scale range: 5 - 35; A higher score indicates more satisfaction with life

  6. Change in Bodily Functioning (measured in survivors)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Short Form 36, physical subscale (SF-36); total scale range: 10 - 30: A higher score indicates worse bodily functioning

  7. Change in Self-Esteem (measured in survivors, siblings, and parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Rosenberg Self-Esteem Scale (RSES); total scale range: 10 - 40: A higher score indicates higher self-esteem

  8. Change in Resilience (measured in survivors and parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Brief Resilience Scale (BRS); total scale range: 6 - 30; A higher score corresponds to being more resilient

  9. Change in Personality (measured in survivors and siblings)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Big Five Inventory 10 (BFI-10); subscales: Extraversion (range: 2 - 10), Agreeableness (range: 2 - 10), Conscientiousness (range: 2 - 10), Neuroticism (range: 2 - 10), Openness (range: 2 - 10); for each scale, a higher score indicates more identification with the scale

  10. Change in Self-Harm (measured in survivors)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Based on Goossens et al., 2013: Health risk behaviors in adolescents and emerging adults with congenital heart disease: psychometric properties of the Health Behavior Scale-Congenital Heart Disease

  11. Change in Perception of Control (measured in survivors, siblings, and parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Multidimensional Health Locus of Control Scale (MHLCS): subscales: Internal Health Locus of Control (range 6 - 36), Powerful Others Health Locus of Control (range 6 - 36), Chance Health Locus of Control (range: 6 - 36); for each scale, a higher score indicates more identification with the scale

  12. Change in Social Support (measured in survivors and siblings)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Multidimensional Scale of Perceived Social Support (MSPSS); subscales: support from special someone (range: 4 - 28), support from family (range: 4 - 28), support from friends (range: 4 - 28); for each subscale, a higher score indicates more support

  13. Change in Contact with Peer Survivors (measured in survivors)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Self-constructed questionnaire

  14. Change in Parental Behavioral Control (measured in survivors, parents, and siblings)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Based on the 8-item Parental Expectations for Behavior Scale and the 8-item Parental Monitoring of Behavior Scale uit de 'Parental Regulation Scale - Youth Self-Report' (PRS -YSR; Barber, 2002); Behavioral Control; total scale range: 7 - 35; A higher score indicates more parental behavioral control

  15. Change in Parental Responsiveness (measured in survivors, parents, and siblings)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Child Report of Parent Behavior Inventory (CRPBI; Schaefer, 1965; Schludermann & Schludermann, 1988); Responsiveness; total scale range: 7 - 35; A higher score indicates more parental responsiveness

  16. Change in Parental Overprotection (measured in survivors, parents, and siblings)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    based on Dutch Multidimensional Overprotective Parenting Scale, Kins & Soenens, 2013; Overprotection / anxious parenting; Overprotection; total scale range: 8 - 40; A higher score indicates more parental overprotection

  17. Change in Parental Psychological Control (measured in survivors, parents, and siblings)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    8-item Psychological Control Scale-Youth Self-Report ( Barber, 1996); Psychological Control; total scale range: 8 - 40; A higher score indicates more parental psychological control

  18. Change in Illness Intrusiveness (measured in parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Illness Intrusiveness Questionnaire Parent Report (IIQ-Parent Report); total scale range: 13 - 91; A higher score indicates more illness intrusiveness

  19. Change in Parental competence (measured in parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Parenting Stress Index - Sense of Competence Scale; total scale range: 13 - 78; A higher score indicates a lower sense of parental competence

  20. Change in Role Restriction (measured in parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Parental Burden Questionnaire, subscale role restriction; total scale range: 6 - 24; A higher score indicates a greater sense of role restriction

  21. Change in Relationship Quality (measured in parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Family Functioning Questionnaire, subscale parental relationship quality; total scale range: 5 - 20; A higher score indicates a greater sense of partner relationship quality

  22. Change in Benefit Finding (measured in parents)

    Time frame: Assessed and reported at baseline, one year later, two years later, and five years later

    Benefit Finding Scale; total scale range: 15 - 105; A higher score indicates more benefit finding

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Collaborators

  • Research Foundation Flanders
  • Universitaire Ziekenhuizen KU Leuven

Registry information

Official study title

The Long-term Impact of Pediatric Cancer on Adolescents, Emerging Adults, and Their Family: Identity, Psychosocial Functioning, and Development

Acronym: LInC

Important dates

Study start
2018
Primary completion
2024
Study completion
2024
First posted
Feb 7, 2018
Registry last updated
Aug 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.